NeueHealth, Inc. (NYSE:NEUE) CEO Sells $76,257.20 in Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 12,440 shares of NeueHealth stock in a transaction on Friday, March 14th. The stock was sold at an average price of $6.13, for a total transaction of $76,257.20. Following the transaction, the chief executive officer now directly owns 249,454 shares of the company’s stock, valued at $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total transaction of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Trading Down 5.6 %

Shares of NEUE opened at $4.85 on Thursday. The firm has a market capitalization of $40.18 million, a P/E ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66. The firm has a fifty day moving average price of $7.11 and a 200-day moving average price of $6.00.

Institutional Trading of NeueHealth

A number of large investors have recently made changes to their positions in NEUE. Partners Group Holding AG purchased a new stake in NeueHealth in the third quarter worth about $463,000. Virtu Financial LLC purchased a new stake in NeueHealth in the fourth quarter worth about $76,000. Finally, Northern Trust Corp lifted its stake in NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the period. 63.88% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their target price on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.